Purdue and Sackler family agree $7.4bn OxyContin settlement newsthirst.
Purdue Pharma and the Sackler family who control it have agreed to pay up to $7.4bn (£6bn) to settle claims regarding its powerful prescription painkiller OxyContin. The deal represents an increase of more than $1bn on a previous settlement that was rejected in 2024 by the US Supreme Court, according to news agencies AP and…